ERBB2 and gastric cancer: In preclinical study, previous report indicated that HGF activation of MET receptors rescued HER2-amplifed gastric cancer cells from lapatinib-induced growth inhibition by re-stimulating the downstream pathways and restoring normal cell-cycle progression [33].